Connect with us and learn more about the ACCELLIX™ Automated Cell Phenotyping Platform at these scientific events…
Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.
Learn more about this strategic acquisition.
Events
Upcoming
Past
Advanced Therapies Europe 2026
September 7, 2026 – September 9, 2026
Barcelona, Spain
Through exceptional experiences we re-imagine the way the advanced therapies industry connects to change lives.
Are you encountering difficulties navigating the European market? Would you be interested in delving into strategies to overcome these obstacles alongside individuals who have firsthand experience with similar challenges? If so, Advanced Therapies Europe offers an ideal platform to explore cutting-edge innovations and glean insights from fellow industry professionals.
CAR-TCR Summit 2026
September 15, 2026 – September 17, 2026
Boston, MA
As cell therapies continue to demonstrate transformative potential in the clinic whilst reaching new milestones for commercial success, the 11th CAR-TCR Summit is returning as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need.
Built by industry for industry, this year’s agenda features end-to-end coverage of every stage of cell therapy development. From breakthroughs in novel engineering and armoring technologies, streamlined manufacturing to meet tight timelines, optimizing pre-clinical models to reviewing clinical data, to efficiently characterizing your cell therapy product.
Whether you’re a C-level strategic leader, or analytical scientist, you’re guaranteed to leave with actionable solutions to combat the challenges currently halting your therapeutic development and effectively translate your cell therapy from bench to bedside.
The cell therapy community is stronger together. Seize your opportunity to come together this September in an industry-focused environment to celebrate a decade of engineering a disease-free world, and solidify your impact on the future of cell therapy development in pursuit of the shared mission of bringing more life-saving therapies to patients in need.
Cell and Gene Meeting on the Mesa 2026
October 5, 2026 – October 7, 2026
Phoenix, AZ
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.
The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
AABB (Association for the Advancement of Blood & Biotherapies) 2026
October 17, 2026 – October 19, 2026
Atlanta, GA
The AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field.
By actively participating in the continuing education programming at the Annual Meeting, physicians and other health care professionals should be able to:
- Disseminate the latest developments in laboratory, clinical, and administrative practices in the fields of blood and biotherapies.
- Foster conversations with colleagues to stimulate scientific research, enhance clinical practice and improve quality management to improve donor and patient safety in transfusion medicine and biotherapies.
- Evaluate state of the art innovations in transfusion medicine and biotherapies.
Advanced Therapies USA 2026
November 4, 2026 – November 5, 2026
Boston, MA
Through exceptional experiences we re-imagine the way the advanced therapies industry connects to change lives.
ATMP Sweden
December 1, 2026 – December 2, 2026
Stockholm, Sweden
ATMP Sweden is a national platform for communication, coordination, and collaboration within the Swedish advanced therapies ecosystem, bringing together stakeholders across academia, healthcare, industry, and public sector to support the development and implementation of Advanced Therapy Medicinal Products (ATMPs).
The association runs the physical ATMP Sweden Conference annually. This event attracts the broadest diversity of swedish ATMP stakeholders that we have access to, and aims to accelerate patient access to efficacious ATMP solutions by fostering knowledge exchange and collaboration. The event strengthens our Swedish and and international ATMP networks, and highlights world leading ATMP activities and the learnings for the field behind them.
CYTO 2026
June 6, 2026 – June 10, 2026
West Palm Beach, FL
CYTO 2026, the 39th annual Congress of the International Society for the Advancement of Cytometry, is the premier, inclusive, and international conference on the many facets of cytometry science and engineering. Guided by this year’s theme, Cytometry: The Next Wave, the meeting will showcase groundbreaking innovations and emerging directions shaping the field. Join us in West Palm Beach, Florida—a destination celebrated for its year-round sunshine, beautiful beaches, vibrant arts scene, and welcoming community. Home to a growing life sciences ecosystem, anchored by leading biomedical research institutes, innovative biotech companies, and renowned medical centers, this unique blend of community spirit and scientific innovation makes West Palm Beach the ideal setting for charting the next wave of cytometry at CYTO 2026.
International Society for Cell & Gene Therapy (ISCT) 2026
May 6, 2026 – May 9, 2026
Dublin, Ireland
With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access. Topics are curated to address the biggest bottlenecks in cell and gene therapy development.
Cell and Gene Meeting on the Med 2026
April 28, 2026 – April 30, 2026
Rome, Italy
The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.
ADVANCED THERAPIES 2026
March 17, 2026 – March 18, 2026
ExCeL, London
The Advanced Therapies Congress is Europe’s largest commerical cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
The conferences brings together a community of 3,300 global executives at ExCeL London, to be inspired by 300 speakers and 75 start-ups over 2 incredible days.
The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start- up companies, researchers, clinicians, academics, HTAs, payers and regulators.
Blood Centers of America (BCA) Advanced Therapies Network
February 17, 2026 – February 19, 2026
Fort Myers, FL
BCA has offered this annual meeting since 2017 for BCA centers and we are proud that this workshop continues to grow in content and attendance each year. Attendees include CEOs, CFOs, MDs, Marketing Managers, Business Development and a variety of center staff.
What you can look forward to while attending this event:
- Learn most up to date information about the advanced therapies market today and anticipated for future.
- Challenges faced by industry.
- Speakers from blood centers and industry with panel discussions.
- BCA network capabilities and areas to develop.
- Provide input to continue to position the BCA network as leading partner.
- Networking with peers, suppliers & industry.
Advanced Therapies Week
February 9, 2026 – February 12, 2026
San Diego, CA
The Cell & Gene Therapy Conference Shaping the Future of Advanced Therapies
In February 2026, San Diego becomes the meeting point for the world’s leading cell and gene therapy conference, bringing together 2,000+ biotech, pharma, CDMO, and investment leaders. Advanced Therapies Week delivers a high-impact experience where scientific progress, partnering, and commercialization intersect. From emerging science to scalable solutions, expect a focused biotech event built for the people shaping the future of advanced therapies.
67th American Society of Hematology (ASH) Annual Meeting and Exposition
December 6, 2025 – December 9, 2025
Orlando, FL
With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
ASH offers premier educational and scientific meetings and workshops for hematology professionals worldwide.
7th Cell Therapy Analytical Development Summit
December 1, 2025 – December 3, 2025
Boston, MA
Remaining the industry’s leading forum for cell therapy analytical professionals, the 7th Cell Therapy Analytical Development Summit will delve into cutting-edge technologies and proven strategies to aid you in demonstrating product safety, functionality, and quality before heading to market.
Covering early- to late-stage assay development, focus your learning and address your specific analytical needs with our refined two-track format. No matter where you are in the product development cycle, gain hands-on expertise from designing predictive potency assays, through to validating and transferring methods for late-phase trials.
Featuring first-hand case studies and experiences from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the National Institute of Health, seize the opportunity to benchmark against peers, exchange solutions to persistent challenges, and strengthen your analytical toolkit, to excel in an increasingly competitive cell therapy landscape.
Donor Selection & Cell Source Summit
November 19, 2025 – November 20, 2025
San Diego, CA
The 3rd Donor Selection & Cell Source Summit returns to San Diego as the premier platform for allogeneic biopharma, blood banks, and apheresis suppliers to unite to pull back the curtain on donor screening strategies, spearhead new donor recruitment and retention strategies to move forward together in ensuring a consistent and reliable supply of starting material required for clinical trials.
Bringing together experts in supply chain, analytical development, quality control, cryobiology, and more, this event is your one-stop shop for scientific and logistical insights into sourcing and scaling donor-derived starting material for late-stage clinical trials.
BioPharma Webinar: Potency Assays and Functional Characterisation-Going Hand-in-Hand during Product Development up to Commercial Licensing
November 13, 2025
The potency assay is a highly critical assay for cell and gene therapy products and is one of the assays on the release specification. The potency assay needs to reflect the main mechanism of action/s of the product and the CQA. Using cellular function characterisation assays during development provides critical insights which help to establish the most relevant and appropriate potency assay for the product.
Presenters: Therese Choquette at Tigen Pharma, Ulrike Herbrand at Charles River Laboratories, and Felix Montero Julian at Accellix
Sponsored by Charles River and Accellix
Register your FREE seat now!
AABB (Association for the Advancement of Blood & Biotherapies) 2025
October 25, 2025 – October 28, 2025
San Diego, CA
The AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field.
By actively participating in the continuing education programming at the Annual Meeting, physicians and other health care professionals should be able to:
- Disseminate the latest developments in laboratory, clinical, and administrative practices in the fields of blood and biotherapies.
- Foster conversations with colleagues to stimulate scientific research, enhance clinical practice and improve quality management to improve donor and patient safety in transfusion medicine and biotherapies.
- Evaluate state of the art innovations in transfusion medicine and biotherapies.
Cell and Gene Meeting on the Mesa 2025
October 6, 2025 – October 8, 2025
Phoenix, AZ
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.
The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
CAR-TCR Summit 2025
September 23, 2025 – September 26, 2025
Boston, MA
As cell therapies continue to demonstrate transformative potential in the clinic whilst reaching new milestones for commercial success, the 10th CAR-TCR Summit is returning as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need.
Built by industry for industry, this year’s agenda features end-to-end coverage of every stage of cell therapy development. From breakthroughs in novel engineering and armoring technologies, streamlined manufacturing to meet tight timelines, optimizing pre-clinical models to reviewing clinical data, to efficiently characterizing your cell therapy product.
Whether you’re a C-level strategic leader, or analytical scientist, you’re guaranteed to leave with actionable solutions to combat the challenges currently halting your therapeutic development and effectively translate your cell therapy from bench to bedside.
The cell therapy community is stronger together. Seize your opportunity to come together this September in an industry-focused environment to celebrate a decade of engineering a disease-free world, and solidify your impact on the future of cell therapy development in pursuit of the shared mission of bringing more life-saving therapies to patients in need.
Advanced Therapies Europe 2025
September 2, 2025 – September 4, 2025
Barcelona, Spain
Through exceptional experiences we re-imagine the way the advanced therapies industry connects to change lives.
Are you encountering difficulties navigating the European market? Would you be interested in delving into strategies to overcome these obstacles alongside individuals who have firsthand experience with similar challenges? If so, Advanced Therapies Europe offers an ideal platform to explore cutting-edge innovations and glean insights from fellow industry professionals.
7th Annual Allogenic Cell Therapies Summit
June 10, 2025 – June 12, 2025
Boston, MA
The 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success. Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targeting novel cell types and streamlining automated manufacturing processes to support scale-up for larger patient populations.
Covering disease indications in both oncology and autoimmunity, connect with expert speakers as they share innovations in non-viral engineering and manufacturing, the latest advancements in cell expansion techniques and benchmark new donor retention strategies for a smoother journey to the clinic and beyond!
CYTO 2025
May 31, 2025 – June 4, 2025
Denver, CO
Join us for the Premier Congress for Cytometry
CYTO 2025, the 38th annual Congress of the International Society for the Advancement of Cytometry will be the premier, inclusive, and international conference on the many facets of cytometry science and engineering. Join us at this year’s conference in Denver, Colorado! It’s known for its warm hospitality, thriving cultural scene, diverse neighborhoods, and natural beauty that combine to create one of the world’s most spectacular cities.
Home to cutting-edge research institutions and a thriving life science industry, the city is a hub for biomedical research, with leading academic institutions and research hospitals. Embodying the “Mile High” city’s breathtaking views and dedication to research will allow for a 2025 CYTO focused exploring the diverse range of scientific interest in Cytometry.
Cell and Gene Meeting on the Med 2025
April 15, 2025 – April 17, 2025
Rome, Italy
The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.
SoCal Flow SUMMIT 2025
April 7, 2025 – April 8, 2025
UC Irvine, CA
The Southern California Flow Cytometry Association (SoCalFlow) brings together research, clinical and biomedical scientists from Los Angeles, Kern, San Luis Obispo, Santa Barbara, San Bernardino, Riverside, Orange County, San Diego and Imperial counties.
SoCalFlow provides opportunities to further the education of its members by hosting scientific talks, workshops and training courses to keep members abreast of recent developments and advances in the field of cytometry.
Northwest Flow Cytometry Society Meeting
March 19, 2025
Seattle, WA
The North West Flow Cytometry Society (NWFCS) is an inclusive scientific community, our goal is to connect core directors and researcher who use flow cytometry in the North West region including Washington, Oregon, and British Columbia.
The purpose of this organization is to foster knowledge exchange and excellence in the field of flow cytometry by organizing scientific meetings, workshops, and seminars.
The organization strives to educate scientists on best practices, experimental guidelines, latest technical developments, and data analysis approaches, with the overarching goal of furthering research and training in the field of single cell analysis. Regular meetings and seminars shall serve as an educational forum for novel ideas, information exchange, and scientific applications of flow cytometry.
Cell Therapy Analytical Development Summit Europe
September 3, 2024 – September 5, 2024
London, UK
Faced with FDA regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with the EMA.
Join analytical development and quality control experts from industry-leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, to tackle challenges from product characterisation to method validation and release preparation.
Seize the chance this September to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward!
International Society for Cell & Gene Therapy
May 29, 2024 – June 1, 2024
Vancouver, Canada
Established in 1992, the International Society for Cell & Gene Therapy (ISCT) is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective therapies to improve patients’ lives worldwide.
ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.
Comprised of over 3,000 cell and gene therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders, and organizations invested in cell and gene therapy translation.
CYTO 2024
May 4, 2024 – May 8, 2024
Edinburgh, Scotland
CYTO 2024, the 37th annual Congress of the International Society for the Advancement of Cytometry will be a premier, inclusive, and international conference on the many facets of cytometry science and engineering. Join us for this year’s conference in Edinburgh, Scotland, a city known for its rich history, literacy and cultural heritage, and stunning architecture. Home to some of the largest and most influential life science organizations; four universities, three teaching hospitals and eleven institutes all dedicated to ground-breaking research. Scotland has a thriving life science community that is known to be one of the best connected and most collaborative in Europe. CYTO 2024 will embody Edinburgh’s dedication to ground-breaking research to shape ideas and innovations for the future.
